Skip to content
Adhera Therapeutics

Adhera Therapeutics

Armesocarb (MLR-1019) is a dopamine reuptake inhibitor designed to reduce dyskinesia by increasing dopamine availability in the brain, thereby modulating dopamine activity.

Cart 0

Your cart is currently empty.

Start Shopping